Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Xencor Inc (XNCR)

Nasdaq Health Care Biotechnology S&P SmallCap 600
$35.75
+1.70 (+4.99%)
Close of Nov 06, 2026 · end-of-day data
Source: Xencor Inc's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$109.02M$46.15M$40.60M$156.70M$122.69M$275.11M$164.58M$174.62M$110.49M$125.58M
Research & development$51.87M$71.77M$97.50M$118.59M$169.80M$192.51M$199.56M$253.60M$227.69M$239.43M
Operating income$44.04M-$43.12M-$79.37M$13.82M-$76.80M$43.77M-$82.47M-$132.36M-$178.41M-$177.50M
Interest expense$21.00K$13.00K$16.00K——$13.00K$13.00K$6.18M$36.64M$31.93M
Pre-tax income$46.12M-$38.95M-$70.41M$27.19M-$69.33M$82.63M-$54.51M-$119.63M-$234.92M-$89.63M
Income tax$991.00K-$463.00K$0$312.00K$0$0$673.00K$13.66M$1.62M$2.50M
Net income$45.12M-$38.49M-$70.41M$26.88M-$69.33M$82.63M-$55.18M-$133.13M-$232.62M-$91.92M
EBITDA$45.51M-$41.09M-$76.12M$18.12M-$71.00M$51.26M-$73.67M-$120.86M-$166.30M-$166.99M
EPS (basic)$1.09$-0.82$-1.31$0.48$-1.21$1.42$-0.93$-2.20$-3.58$-1.24
EPS (diluted)$1.07$-0.82$-1.31$0.46$-1.21$1.37$-0.93$-2.20$-3.58$-1.24
Diluted shares42.39M46.82M53.94M58.47M57.21M60.50M59.65M60.50M65.04M74.24M
Operating margin40.4%-93.4%-195.5%8.8%-62.6%15.9%-50.1%-75.8%-161.5%-141.4%
Net margin41.4%-83.4%-173.4%17.2%-56.5%30.0%-33.5%-76.2%-210.5%-73.2%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$14.53M$16.53M$26.25M$50.31M$163.54M$143.48M$53.94M$53.79M$40.88M$54.07M
Short-term investments$115.61M$207.60M$268.12M$479.47M——————
Receivables$8.62M$1.14M$10.19M$21.57M$11.44M$66.38M$29.00M$23.74M$60.85M$29.30M
Total current assets$141.65M$230.88M$315.73M$558.40M$637.67M$424.37M$675.34M$635.60M$577.60M$599.82M
Total assets$428.56M$390.20M$576.73M$670.25M$703.24M$838.21M$846.27M$965.13M$951.95M$875.50M
Total current liabilities$106.29M$72.65M$53.85M$66.56M$121.06M$70.74M$63.84M$73.92M$87.43M$95.91M
Short-term debt——————$0$27.71M$48.45M$43.27M
Long-term debt——————$0$161.77M$115.16M$76.48M
Total debt——————$0$189.48M$163.61M$119.75M
Total liabilities$114.61M$73.74M$55.05M$77.05M$130.80M$104.71M$118.77M$303.05M$277.92M$239.91M
Shareholders' equity$337.93M$316.46M$521.68M$593.20M$572.44M$733.50M$727.50M$661.75M$677.61M$635.59M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$95.24M-$33.60M-$79.76M$64.37M-$5.00M-$16.85M$24.48M-$77.93M-$202.19M-$135.12M
Capital expenditures$1.51M$5.31M$7.21M$7.35M$10.54M$13.30M$38.49M$18.45M$6.10M$3.15M
Free cash flow$93.73M-$38.91M-$86.97M$57.02M-$15.54M-$30.15M-$14.01M-$96.37M-$208.28M-$138.27M
Investing cash flow-$214.27M$31.86M-$164.77M-$50.97M$100.19M-$46.25M-$119.72M-$111.06M-$7.87M$139.99M
Financing cash flow$120.97M$3.73M$254.24M$10.66M$18.04M$43.04M$5.70M$189.22M$197.15M$8.23M
Stock-based compensation$7.85M$13.65M$20.55M$31.85M$31.62M$36.98M$48.91M$53.76M$53.28M$43.23M
Depreciation & amortization$1.47M$2.03M$3.25M$4.30M$5.79M$7.49M$8.80M$11.50M$12.11M$10.51M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.